HomeSJS › Filing
🔔 Get instant alerts when SJS files quarterly results on BSE Start free trial →

Investor Presentation

Filed: 06 Aug 2026, 14:56 IST Exchange: BSE Category: Financial Results — Investor Presentation
AI summary - Q1FY27 revenue grew 24.5% YoY to Rs 2,610 Mn; EBITDA rose 36.2% YoY to Rs 799.6 Mn with 30.0% margin - PAT surged 115.0% YoY to Rs 744.2 Mn; Normalised PAT up 45.2% YoY at Rs 502.5 Mn, margin 19.3% - Domestic sales grew 20.3% YoY; exports up 83.2% YoY to Rs 255.7 Mn - Board approved new subsidiary for cover glass & displays manufacturing - FY27 outlook: expects 1.5-2x industry growth, robust margin, 88% order book coverage - Strong cash flow; net cash Rs 3,287.7 Mn; ICRA upgraded rating to AA- (Positive) - Expansion: new Pune plant started; optical display facility ready; capacity expansion ongoing - Focus on premium products, new technologies, global market expansion, and mega accounts growth
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 SJS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add SJS to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on S.J.S. Enterprises Limited

Important. The summary above is generated automatically from S.J.S. Enterprises Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.